Slade M, Fiala MA, Kirchmeyer M, King J, Gao F, Schroeder MA, A Stewart K, Stockerl-Goldstein K, Chen C, Vij R.
Continuous Elotuzumab, Pomalidomide and Dexamethasone Maintenance Following Second Autologous Transplant for Multiple Myeloma: Results of a Prospective, Phase 2 Multicenter Trial. Transplant Cell Ther. 2023.